| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | 0.16 | 0.004 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | 0.11 | 0.04 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.09 | 0.08 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | 0.067 | 0.2 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | 0.065 | 0.2 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.06 | 0.3 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.055 | 0.3 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | 0.047 | 0.4 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.043 | 0.4 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | 0.049 | 0.4 |